Skip to main content
SpringerLink
Log in

Diabetes Epidemiology and Its Implications

  • Chapter
  • First Online:
Lipoproteins in Diabetes Mellitus

Part of the book series: Contemporary Diabetes ((CDI))

  • 446 Accesses

Abstract

Diabetes is epidemic around the world. It is estimated that by the year 2040, approximately 740 million persons will have diabetes, the majority with type 2 diabetes, and many undiagnosed. The leading cause of this is the growing prevalence of persons being overweight or obese. Another key factor is that the world’s population is growing older, a well-documented risk factor for developing diabetes. Persons with diabetes are also living longer because both their diabetes and their various cardiovascular comorbidities are being treated with greater efficacy. Genetic predisposition, lack of or inadequate physical activity, air pollution, and other environmental factors also contribute to overall risk escalation for developing diabetes. Diabetes greatly magnifies the risk for the development of both microvascular (proliferative retinopathy, nephropathy, and neuropathy) and macrovascular diseases (coronary, carotid/cerebral, and peripheral vascular disease), greatly straining the healthcare resources of all nations. Greater effort will have to be put forth on the part of public health initiatives to stem the tide of persons afflicted with new-onset diabetes.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. West K. Epidemiology of diabetes and its vascular complications. New York: Elsevier; 1978.

    Google Scholar 

  2. Gregg EW, Li Y, Wang J, Burrows NR, Ali MK, Rolka D, Williams DE, Geiss L. Changes in diabetes-related complications in the United States, 1990-2010. N Engl J Med. 2014;370(16):1514–23.

    Article  CAS  PubMed  Google Scholar 

  3. Zghebi SS, Steinke DT, Carr MJ, Rutter MK, Emsley RA, Ashcroft DM. Examining trends in type 2 diabetes incidence, prevalence and mortality in the UK between 2004 and 2014. Diabetes Obes Metab. 2017;19(11):1537–45.

    Article  PubMed  Google Scholar 

  4. Carstensen B, Rønn PF, Jørgensen ME. Components of diabetes prevalence in Denmark 1996-2016 and future trends until 2030. BMJ Open Diabetes Res Care. 2020;8(1):e001064.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Kim D, Li AA, Cholankeril G, Kim SH, Ingelsson E, Knowles JW, Harrington RA, Ahmed A. Trends in overall, cardiovascular and cancer-related mortality among individuals with diabetes reported on death certificates in the United States between 2007 and 2017. Diabetologia. 2019;62(7):1185–94.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Dubowitz N, Xue W, Long Q, Ownby JG, Olson DE, Barb D, Rhee MK, Mohan AV, Watson-Williams PI, Jackson SL, Tomolo AM, Johnson TM 2nd, Phillips LS. Aging is associated with increased HbA1c levels, independently of glucose levels and insulin resistance, and also with decreased HbA1c diagnostic specificity. Diabet Med. 2014;31(8):927–35.

    Article  CAS  PubMed  Google Scholar 

  7. Chivese T, Hirst J, Matizanadzo JT, Custodio M, Farmer A, Norris S, Levitt N. The diagnostic accuracy of HbA1c, compared to the oral glucose tolerance test, for screening for type 2 diabetes mellitus in Africa-A systematic review and meta-analysis. Diabet Med. 2021;39:e14754.

    PubMed  Google Scholar 

  8. Albitres-Flores L, Bernabe-Ortiz A. Diagnostic accuracy of ADA 2020 criteria for undiagnosed diabetes in a Peruvian population. Diabetes Res Clin Pract. 2020;169:108475.

    Article  CAS  PubMed  Google Scholar 

  9. Jørgensen ME, Bjerregaard P, Borch-Johnsen K, Witte D. New diagnostic criteria for diabetes: is the change from glucose to HbA1c possible in all populations? J Clin Endocrinol Metab. 2010;95(11):E333–6.

    Article  PubMed  Google Scholar 

  10. Bloomgarden Z. Beyond HbA1c. J Diabetes. 2017;9(12):1052–3.

    Article  PubMed  Google Scholar 

  11. NCD Risk Factor Collaboration (NCD-RisC). Effects of diabetes definition on global surveillance of diabetes prevalence and diagnosis: a pooled analysis of 96 population-based studies with 331,288 participants. Lancet Diabetes Endocrinol. 2015;3(8):624–37.

    Article  Google Scholar 

  12. Norris JM, Johnson RK, Stene LC. Type 1 diabetes-early life origins and changing epidemiology. Lancet Diabetes Endocrinol. 2020;8(3):226–38.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Diaz-Valencia PA, Bougnères P, Valleron AJ. Global epidemiology of type 1 diabetes in young adults and adults: a systematic review. BMC Public Health. 2015;15:255ax.

    Article  Google Scholar 

  14. Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, Colagiuri S, Guariguata L, Motala AA, Ogurtsova K, Shaw JE, Bright D, Williams R, IDF Diabetes Atlas Committee. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract. 2019;157:107843.

    Article  PubMed  Google Scholar 

  15. International Diabetes Federation. IDF diabetes atlas. 10th ed. https://diabetesatlas.org/resources/. Accessed 12 Dec 2021.

  16. Luhar S, Kondal D, Jones R, Anjana RM, Patel SA, Kinra S, Clarke L, Ali MK, Prabhakaran D, Kadir MM, Tandon N, Mohan V, Narayan KMV. Lifetime risk of diabetes in metropolitan cities in India. Diabetologia. 2021;64(3):521–9.

    Article  PubMed  Google Scholar 

  17. https://gis.cdc.gov/grasp/diabetes/DiabetesAtlas.html#. Accessed 5 Sept 2021.

  18. Wang L, Li X, Wang Z, Bancks MP, Carnethon MR, Greenland P, Feng YQ, Wang H, Zhong VW. Trends in prevalence of diabetes and control of risk factors in diabetes among US adults, 1999-2018. JAMA. 2021;326(8):1–13.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Xia PF, Pan XF, Li Y, Guo K, Yang K, Tu ZZ, Zhang YB, Geng TT, Liu G, Pan A. Trends in diagnosed and undiagnosed diabetes among adults in the U.S., 2005-2016. Diabetes Care. 2021;44(9):e175–7.

    Article  CAS  PubMed  Google Scholar 

  20. Panton UH, Bagger M, Barquera S. Projected diabetes prevalence and related costs in three North American urban centres (2015-2040). Public Health. 2018;157:43–9.

    Article  PubMed  Google Scholar 

  21. Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS, Marks JS. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA. 2003;289(1):76–9.

    Article  PubMed  Google Scholar 

  22. Adult Obesity Facts. 2021. https://www.cdc.gov/obesity/data/adult.html. Accessed 11 Oct 2021.

  23. Estimates of Diabetes and Its Burden in the United States. 2021. https://www.cdc.gov/diabetes/data/statistics-report/index.html. Accessed 11 Oct 2021.

  24. Seiglie JA, Marcus ME, Ebert C, Prodromidis N, Geldsetzer P, Theilmann M, Agoudavi K, Andall-Brereton G, Aryal KK, Bicaba BW, Bovet P, Brian G, Dorobantu M, Gathecha G, Gurung MS, Guwatudde D, Msaidié M, Houehanou C, Houinato D, Jorgensen JMA, Kagaruki GB, Karki KB, Labadarios D, Martins JS, Mayige MT, Wong-McClure R, Mwangi JK, Mwalim O, Norov B, Quesnel-Crooks S, Silver BK, Sturua L, Tsabedze L, Wesseh CS, Stokes A, Atun R, Davies JI, Vollmer S, Bärnighausen TW, Jaacks LM, Meigs JB, Wexler DJ, Manne-Goehler J. Diabetes prevalence and its relationship with education, wealth, and BMI in 29 low- and middle-income countries. Diabetes Care. 2020;43(4):767–75.

    Article  PubMed  PubMed Central  Google Scholar 

  25. He W, Li Q, Yang M, Jiao J, Ma X, Zhou Y, Song A, Heymsfield SB, Zhang S, Zhu S. Lower BMI cutoffs to define overweight and obesity in China. Obesity (Silver Spring). 2015;23(3):684–91.

    Article  PubMed  Google Scholar 

  26. WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363(9403):157–63.

    Article  Google Scholar 

  27. Teufel F, Seiglie JA, Geldsetzer P, Theilmann M, Marcus ME, Ebert C, Arboleda WAL, Agoudavi K, Andall-Brereton G, Aryal KK, Bicaba BW, Brian G, Bovet P, Dorobantu M, Gurung MS, Guwatudde D, Houehanou C, Houinato D, Jorgensen JMA, Kagaruki GB, Karki KB, Labadarios D, Martins JS, Mayige MT, McClure RW, Mwangi JK, Mwalim O, Norov B, Crooks S, Farzadfar F, Moghaddam SS, Silver BK, Sturua L, Wesseh CS, Stokes AC, Essien UR, De Neve JW, Atun R, Davies JI, Vollmer S, Bärnighausen TW, Ali MK, Meigs JB, Wexler DJ, Manne-Goehler J. Body-mass index and diabetes risk in 57 low-income and middle-income countries: a cross-sectional study of nationally representative, individual-level data in 685 616 adults. Lancet. 2021;398(10296):238–48.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Caspard H, Jabbour S, Hammar N, Fenici P, Sheehan JJ, Kosiborod M. Recent trends in the prevalence of type 2 diabetes and the association with abdominal obesity lead to growing health disparities in the USA: an analysis of the NHANES surveys from 1999 to 2014. Diabetes Obes Metab. 2018;20(3):667–71.

    Article  PubMed  Google Scholar 

  29. Wong MCS, Huang J, Wang J, Chan PSF, Lok V, Chen X, Leung C, Wang HHX, Lao XQ, Zheng ZJ. Global, regional and time-trend prevalence of central obesity: a systematic review and meta-analysis of 13.2 million subjects. Eur J Epidemiol. 2020;35(7):673–83.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Cho NH, Shaw JE, Karuranga S, Huang Y, da Rocha Fernandes JD, Ohlrogge AW, Malanda B. IDF Diabetes Atlas: global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018;138:271–81.

    Article  CAS  PubMed  Google Scholar 

  31. Bloomgarden Z, Ning G. Diabetes and aging. J Diabetes. 2013;5:369–71.

    Article  PubMed  Google Scholar 

  32. Zhang X, Decker FH, Luo H, et al. Trends in the prevalence and comorbidities of diabetes mellitus in nursing home residents in the United States: 1995–2004. J Am Geriatr Soc. 2010;58:724–30.

    Article  PubMed  Google Scholar 

  33. Sloan FA, Bethel MA, Ruiz D Jr, Shea AM, Feinglos MN. The growing burden of diabetes mellitus in the US elderly population. Arch Intern Med. 2008;168:192–9.

    Article  PubMed  Google Scholar 

  34. Chittleborough CR, Grant JF, Phillips PJ, Taylor AW. The increasing prevalence of diabetes in South Australia: the relationship with population ageing and obesity. Public Health. 2007;121:92–9.

    Article  CAS  PubMed  Google Scholar 

  35. Lin CC, Li CI, Hsiao CY, et al. Time trend analysis of the prevalence and incidence of diagnosed type 2 diabetes among adults in Taiwan from 2000 to 2007: a population-based study. BMC Public Health. 2013;13:318.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Narayan KM, Boyle JP, Geiss LS, Saaddine JB, Thompson TJ. Impact of recent increase in incidence on future diabetes burden: U.S., 2005–2050. Diabetes Care. 2006;29:2114–6.

    Article  PubMed  Google Scholar 

  37. Andes LJ, Li Y, Srinivasan M, Benoit SR, Gregg E, Rolka DB. Diabetes prevalence and incidence among Medicare beneficiaries—United States, 2001-2015. MMWR Morb Mortal Wkly Rep. 2019;68(43):961–6.

    Article  PubMed  PubMed Central  Google Scholar 

  38. International Diabetes Federation Diabetes Atlas. 9th ed. Brussels, Belgium; 2019. https://www.diabetesatlas.org.

  39. Walker JD, Slater M, Jones CR, Shah BR, Frymire E, Khan S, Jacklin K, Green ME. Diabetes prevalence, incidence and mortality in First Nations and other people in Ontario, 1995-2014: a population-based study using linked administrative data. CMAJ. 2020;192(6):E128–35.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Ferguson LD, Ntuk UE, Celis-Morales C, Mackay DF, Pell JP, Gill JMR, Sattar N. Men across a range of ethnicities have a higher prevalence of diabetes: findings from a cross-sectional study of 500 000 UK Biobank participants. Diabet Med. 2018;35(2):270–6.

    Article  CAS  PubMed  Google Scholar 

  41. Geiss LS, Kirtland K, Lin J, Shrestha S, Thompson T, Albright A, Gregg EW. Changes in diagnosed diabetes, obesity, and physical inactivity prevalence in US counties, 2004-2012. PLoS One. 2017;12(3):e0173428.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Divney AA, Murillo R, Rodriguez F, Mirzayi CA, Tsui EK, Echeverria SE. Diabetes prevalence by leisure-, transportation-, and occupation-based physical activity among racially/ethnically diverse U.S. adults. Diabetes Care. 2019;42(7):1241–7.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Zhao F, Wu W, Feng X, Li C, Han D, Guo X, Lyu J. Physical activity levels and diabetes prevalence in US adults: findings from NHANES 2015-2016. Diabetes Ther. 2020;11(6):1303–16.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Seixas AA, Henclewood DA, Langford AT, McFarlane SI, Zizi F, Jean-Louis G. Differential and combined effects of physical activity profiles and prohealth behaviors on diabetes prevalence among blacks and whites in the US population: a novel Bayesian belief network machine learning analysis. J Diabetes Res. 2017;2017:5906034.

    Article  PubMed  PubMed Central  Google Scholar 

  45. Zhang X, Geiss LS, Caspersen CJ, Cheng YJ, Engelgau MM, Johnson JA, Plotnikoff RC, Gregg EW. Physical activity levels and differences in the prevalence of diabetes between the United States and Canada. Prev Med. 2010;50(5–6):241–5.

    Article  PubMed  Google Scholar 

  46. Elbarbary M, Honda T, Morgan G, Kelly P, Guo Y, Negin J. Ambient air pollution exposure association with diabetes prevalence and glycosylated hemoglobin (HbA1c) levels in China. Cross-sectional analysis from the WHO study of AGEing and adult health wave 1. J Environ Sci Health A Tox Hazard Subst Environ Eng. 2020;55(10):1149–62.

    Article  CAS  PubMed  Google Scholar 

  47. Guo C, Yang HT, Chang LY, Bo Y, Lin C, Zeng Y, Tam T, Lau AKH, Hoek G, Lao XQ. Habitual exercise is associated with reduced risk of diabetes regardless of air pollution: a longitudinal cohort study. Diabetologia. 2021;64(6):1298–308.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Icahn School of Medicine, Mount Sinai Medical Center, New York, NY, USA

    Zachary Bloomgarden

  2. Metabolic Institute of America, Tarzana, CA, USA

    Yehuda Handelsman

Authors
  1. Zachary Bloomgarden
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yehuda Handelsman
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. NHMRC Clinical Trials Centre, University of Sydney, Sydney, NSW, Australia

    Alicia J. Jenkins

  2. Department of Medicine, Division of Cardiology, Johns Hopkins University School of Medicine, Baltimore, MD, USA

    Peter P. Toth

Rights and permissions

Reprints and permissions

Copyright information

© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Bloomgarden, Z., Handelsman, Y. (2023). Diabetes Epidemiology and Its Implications. In: Jenkins, A.J., Toth, P.P. (eds) Lipoproteins in Diabetes Mellitus. Contemporary Diabetes. Humana, Cham. https://doi.org/10.1007/978-3-031-26681-2_31

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-26681-2_31

  • Published:

  • Publisher Name: Humana, Cham

  • Print ISBN: 978-3-031-26680-5

  • Online ISBN: 978-3-031-26681-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation